|Articles|November 6, 2015
Elevating the Patient Voice: Leveraging Patients' Expertise to Advance Drug Development
Author(s)DIA
Advertisement
A report on progress with PDUFA V commitments to hold patient-focused drug development meetings; and on how patient focus is being built into 21st Century Cures legislation and forthcoming PDUFA VI reauthorization.
This article appeared in the August 2015 issue of
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Lilly Reduces Price of Zepbound Single-Dose Vials for Self-Pay Patients
2
Report: FDA to Change Vaccine Approval Process Based on Agency’s Claim of Covid Vaccine-Related Deaths
3
Korea and Australia's P&MA Shift: From Local Launch Opportunities to Regional Blueprint
4
Pharmaceutical Executive Daily: U.S. & U.K. Agree to 0% Tariffs on Pharmaceutical Products
5
